|
|
|||
Metachromatic Leukodystrophy (MLD) is characterized by loss of motor and intellectual functions. There are three clinical subtypes: late-infantile MLD (50-60%), juvenile MLD (20-30%) and adult MLD (15-20%). It is caused by a deficiency of the arylsulfatase A (ARSA) gene which leads to an impaired breakdown of sulfatides, sulfate-containing lipids that occur throughout the body and are in the highest abundance in the nervous tissue, kidneys and testes. Sulfatide accumulation in the nervous system leads to myelin breakdown or leukodystrohy. This disease is inherited in an autosomal recessive manner. Reasons for Referral:
Testing Methodology:PCR amplification of the exons contained in the ARSA gene coding region will be performed on patient genomic DNA. Direct sequencing of amplification products is performed in both the forward and reverse directions using automated fluorescence dideoxy sequencing methods. Specimen Requirements:Blood: EDTA (purple-top) tubes: Adults: 14
cc; Child: 6 cc; Infant: 2-3 cc Turnaround Time:Index: 4 weeks CPT Codes and Prices:
Index: 83891, 83898x6, 83894, 83904x12, 83909x12, 83912 References:1. Berger J, Loschl B, Bernheimer H, Lugowska A, Tylki-Szymanska A, Gieselmann V, Molzer B. Occurrence, distribution, and phenotype of arylsulfatase A mutations in patients with metachromatic leukodystrophy. Am. J. Med. Genet. 1997; 69: 335–40. Shipping InformationForms: >> Gene
Sequencing Requisition Test Codes:Index: 6380 |